DAINIP S'TOMO PHARM
There is no Profile data available for DPM.BE.
DAINIP S'TOMO PHARM (DPM) - Total Liabilities
Latest total liabilities as of March 2025: €573.12 Billion EUR
Based on the latest financial reports, DAINIP S'TOMO PHARM (DPM) has total liabilities worth €573.12 Billion EUR as of March 2025.
Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities.
DAINIP S'TOMO PHARM - Total Liabilities Trend (2017–2025)
This chart illustrates how DAINIP S'TOMO PHARM's total liabilities have evolved over time, based on quarterly financial data. Explore and compare other companies by total liabilities.
DAINIP S'TOMO PHARM Competitors by Total Liabilities
The table below lists competitors of DAINIP S'TOMO PHARM ranked by their total liabilities.
| Company | Country | Total Liabilities |
|---|---|---|
|
Essex Minerals Inc
PINK:ESXMF
|
USA | $1.08 Million |
|
NEOPOST - Dusseldorf Stock Exchang
DU:NEQ
|
Germany | €1.48 Billion |
|
RTX (RTE.SG)
STU:RTE
|
Germany | €167.51 Million |
Liability Composition Analysis (2017–2025)
This chart breaks down DAINIP S'TOMO PHARM's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted.
Liquidity & Leverage Metrics
Key Metrics Explained
| Metric | Value | Description |
|---|---|---|
| Current Ratio | 1.05 | Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities) |
| Quick Ratio | N/A | More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities) |
| Cash Ratio | N/A | Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities) |
| Debt to Equity | 3.38 | Measures financial leverage (Total Liabilities ÷ Shareholder Equity) |
| Debt to Assets | 0.77 | Portion of assets financed with debt (Total Liabilities ÷ Total Assets) |
Liability Trends Comparison
This chart compares key liability metrics across different time periods, showing how DAINIP S'TOMO PHARM's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.
Annual Total Liabilities for DAINIP S'TOMO PHARM (2017–2025)
The table below shows the annual total liabilities of DAINIP S'TOMO PHARM from 2017 to 2025.
| Year | Total Liabilities | Change |
|---|---|---|
| 2025-03-31 | €573.12 Billion | -23.72% |
| 2024-03-31 | €751.37 Billion | +3.22% |
| 2023-03-31 | €727.96 Billion | +14.74% |
| 2022-03-31 | €634.44 Billion | -3.87% |
| 2021-03-31 | €659.95 Billion | +6.31% |
| 2020-03-31 | €620.77 Billion | +84.44% |
| 2019-03-31 | €336.58 Billion | -5.71% |
| 2018-03-31 | €356.96 Billion | +7.10% |
| 2017-03-31 | €333.29 Billion | -- |